High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.
Also called NCT05958537
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 132 participants
- Sponsor
- Registry
-
NCT05958537
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Spain
- Registry status
- Completed
Technical summary
Registry record NCT05958537. Randomized; no masking; primary purpose treatment. Start 2023-11-01 (actual); primary completion 2024-07-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High Flow Nasal Oxygen Cannula in Transcatheter Aortic Valve Replacement: Complications and Biomarkers
- Acronym
- HIGH-OXY-TAVR
- Condition
- Aortic Stenosis
- Condition
- Sedation Complication
- Intervention (Device)
- High flow nasal oxygen
- Lead sponsor
- Hospital Clinic of Barcelona
Record details
- Record id
cardio:ct-nct05958537- Content hash
4e48e1f2682729f4e85cb0f8b5434db1dad242955f92f98097a6423207006751